Final answer:
The time frame for reporting disciplinary actions to the TN BoP is not provided in the LibreTexts™ information. Instead, LibreTexts™ discusses reporting requirements for pharmaceutical sponsors to the FDA. The TN BoP's exact reporting requirements should be checked through their regulation documentation or direct contact.
Step-by-step explanation:
The specific time frame for a compounding pharmacy with a Tennessee (TN) license to report disciplinary actions by any other regulatory agency to the Tennessee Board of Pharmacy (TN BoP) may not be directly provided in the information given from LibreTexts™. While LibreTexts™ does not provide the reporting requirements for the Tennessee Board of Pharmacy, it does detail the responsibilities of a pharmaceutical sponsor after receiving New Drug Application (NDA) approval by the Food and Drug Administration (FDA). According to this information, sponsors are required to report every patient adverse drug experience, with serious and fatal events needing to be reported within 15 days, and other events on a quarterly basis. However, to answer the student's specific question, one would need to refer to the TN BoP regulations or contact the TN BoP directly for the most accurate and current reporting requirements.